Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$34.32 - $57.55 $339,218 - $568,824
9,884 New
9,884 $553,000
Q2 2023

Aug 14, 2023

SELL
$50.96 - $58.72 $578,446 - $666,530
-11,351 Reduced 45.94%
13,356 $745,000
Q1 2023

May 09, 2023

BUY
$35.33 - $55.79 $872,898 - $1.38 Million
24,707 New
24,707 $1.38 Million
Q1 2022

May 16, 2022

SELL
$55.7 - $145.79 $85,388 - $223,496
-1,533 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$135.05 - $182.59 $207,031 - $279,910
1,533 New
1,533 $228,000
Q1 2021

May 12, 2021

SELL
$140.25 - $196.86 $346,277 - $486,047
-2,469 Closed
0 $0
Q4 2020

Feb 05, 2021

BUY
$126.47 - $163.7 $312,254 - $404,175
2,469 New
2,469 $352,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.